Position in NNVC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$177,468
+$54,709 QoQ
Shares Held
128,600
-4.7% QoQ
Ownership
0.594%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 48 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NNVC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. NNVC ranks #258 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in NNVC
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $177,468 | 128,600 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $122,759 | 134,900 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $195,945 | 173,403 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $301,015 | 210,500 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $155,960 | 111,400 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $123,786 | 105,800 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $208,351 | 145,700 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $172,350 | 114,900 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $175,612 | 102,100 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $98,020 | 84,500 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $80,070 | 78,500 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $101,974 | 76,100 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $90,390 | 78,600 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $83,179 | 71,094 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $85,440 | 76,973 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $122,944 | 71,066 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $112,800 | 60,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $160,512 | 76,800 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $165,912 | 44,600 | Shares | Sole | 2022-02-11 | |
| 2020-12-31 | $217,009 | 75,613 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||